Business Wire

GEKKOVET-OY

17.6.2021 11:34:12 CEST | Business Wire | Press release

Share
GekkoVet Oy: Has My Dog Got Corona Virus Disease, Cholangitis or Kennel Cough?

There are hundreds of different diseases and even more symptoms that can affect pets. Even a veterinarian cannot remember all of them without help. The new GekkoCompass application, recently launched by a Finnish company, suggests the most probable diagnosis and the appropriate treatment at the touch of a button to the veterinarian.

In treating their patients, veterinarians use numerous different sources to arrive at a diagnosis. Now, however, there is no longer a need for stacks of books or confusing notes. GekkoCompass creates a list of possible diagnoses in probability order, based on the patient’s symptoms, laboratory results, and other findings. After the diagnosis is selected, the appropriate treatments are suggested to the veterinarian. GekkoCompass provides support throughout the patient's treatment chain reducing the risk of human error at all stages. It does not forget things and preconceptions will not influence the diagnoses suggested.

GekkoCompass currently includes information for internal diseases of dogs and cats. With these alone there are nearly 25,000 different disease-symptom combinations. The content will grow to embrace new animal species as well as different fields of veterinary medicine. All this information is available to all veterinarians worldwide - regardless of the level of veterinary education or the country’s resources.

Johanna Majamaa, CEO of GekkoVet Oy, states: “The main idea behind this application’s development has been the desire to promote animal welfare worldwide. With GekkoCompass, the veterinarian will find diagnoses and recommended treatments faster and with greater confidence. At the same time, information is accumulated as veterinary medicine real world data (RWD). This is the first time ever when this data is automatically structured along the patient treatment path. PetCompass, a sister product that we have just launched, arose out of this same idea, but is intended for pet owners. We thought, why not provide professional-level information to animal owners as well and facilitate the flow of information between owners and veterinarians?”

Until now, pet owners have had to look for pet health information from a variety of sources, the reliability of which varies greatly. Now up-to-date information on the pet’s condition is easily available in one place through the PetCompass mobile app.

GekkoVet Oy is working with If P&C Insurance, which offers its dog and cat insurance customers the Premium version of the PetCompass application for 3 months free of charge. “During the corona pandemic, the number of new pet owners has grown sharply. We want to help, especially, the less experienced dog and cat owners by offering peace of mind in the different everyday situations that they and their pets find themselves in. The application provides a reliable and effortless way to discover the causes of a pet's symptoms and to easily get in touch with a veterinarian (or a remote veterinarian) if this is necessary,” says Heidi Elomaa, If's veterinarian and Product Manager for Animal Insurance.

Link:

ClickThru

Social Media:

https://www.facebook.com/gekkovet

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Energy Impact Partners Expands Nordic Investment Presence, Deepening Partnership with Nysnø Climate Investments3.8.2026 08:02:00 CEST | Press release

EIP reinforces commitment to Norway as a defining center for next-generation energy innovation Energy Impact Partners LP ("EIP"), a global investment firm with over $5 billion in assets under management, today announced an expanded commitment to the Nordic energy innovation ecosystem, building on its longstanding strategic partnership with Nysnø Climate Investments ("Nysnø"). The expansion reflects EIP's conviction that Norway and the broader Nordic region will be a defining source of next-generation energy companies. It also marks a deepening of the firm's institutional relationship with Nysnø, an investor in EIP's $1.36 billion flagship fund. Together, the two firms aim to strengthen connectivity between Nordic founders and EIP's global network spanning venture capital, private equity, and credit. "Norway is one of the most sophisticated and forward-looking energy markets in the world," said Matthias Dill, CEO & Managing Partner, Europe at EIP. "We believe many of the defining compan

First Plus Expands Relationship with SS&C to Support Cross-Border Operations in APAC3.8.2026 03:00:00 CEST | Press release

SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that First Plus Asset Management (FPAM), a multi-asset investment management firm, has selected SS&C to provide cross-border operations support across Asia. SS&C will service First Plus across the full investment lifecycle, delivering a scalable, integrated solution supporting transfer agency, order management and execution and investment accounting. FPAM will utilize SS&C to service its growing cross-border operating model and support around $200 million in assets under management*. “As First Plus has expanded, managing our operations has become increasingly complex,” said Jeb Li, Co-Founder and CEO at First Plus. “SS&C’s global footprint and integrated offerings enable us to easily optimize our workflows, so we can focus on scaling quickly and securely while continuing to deliver risk-adjusted returns and best-in-class client service.” The engagement highlights the breadth and scalability of SS&C’s global service model.

Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release

Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release

Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release

Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye